Stepping-Stones Towards Triple Agonism: A Summary of GLP-1/GIP and GLP-1/GCG Dual-Agonist Development The development of triple agonists for obesity has built upon successes of several dual combinations of entero-pancreatic hormone receptor agonists, in particular, GLP-1/GIP dual agonists and GLP-1/GCG dual agonists
These belches could smell like sulfur based on the way Wegovy changes the gut microbiome
Investigators have examined its interactions with the hypothalamic-pituitary-adrenal (HPA) axis, stress response systems, and neuroendocrine signaling, as well as its apparent ability to cross the blood-brain barrier under certain experimental conditions
Jardiances half-life is approximately 12 hours, but it typically takes about five half-lives for a medication to be completely eliminated from the body, which would be two to three days with Jardiance
While the exact mechanisms by which tirzepatide produces weight loss are not fully understood, the medication appears to work through multiple pathways
Kaufmans biggest concern with increasing the dose and producing side effects is not weight loss but gut motility
